News
The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with generalized ...
HealthDay on MSN10d
FDA Approves Self-Injection of Vyvgart HytruloWEDNESDAY, April 16, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved a self-injection version of ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa ...
FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.
DigiVibe™ employs advanced vibration technology to minimize pain perception, making self-injection more manageable for users. The newly launched website offers: User-Centric Design: An intuitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback